Key facts
- This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Apr 2022, 18:49.
John E. Kao - 31 Mar 2022 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ALHC
- Reported as of
- 31 Mar 2022
- Net transaction value
- -$294,656
- SEC form
- 4
- Accepted by SEC
- 01 Apr 2022, 18:49:35 UTC
- Prior SEC filing
- 10 Mar 2022
- Next SEC filing
- 08 Jul 2022
- Source filing
- View source filing
- Reporting owner signature
- Richard A. Cross, as Attorney-in-Fact, for John E. Kao
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 01 Apr 2022.
Change
- Previous filing in this sequence was filed on 10 Mar 2022.
- Current net transaction value: -$294,656.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALHC
transaction
Common Stock
Sale
- Transaction value
- $294,656
- Shares
- -26,366
- Change %
- -3.3%
- Price
- $11.18
- Shares after
- 781,353
- Date
- 31 Mar 2022
- Ownership
- Direct
- Footnotes
- F1, F2
ALHC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,565,391
- Date
- 31 Mar 2022
- Ownership
- See Footnote
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
Footnote F2
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Footnote F3
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.